Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the Schedule of the Analysts / Institutional Investors Meeting with the Company. Zim Laboratories Ltd - 541400 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Piyush NikhadeDesignation :- Company Secretary and Compliance Officer Zim Laboratories Ltd - 541400 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith Certificate dt. 07.07.2022 issued by Link Intime India Private Limited, Mumbai, Registrar and Transfer Agent (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Zim Laboratories Ltd - 541400 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Zim Laboratories Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Zim Laboratories Ltd - 541400 - Voting Results Of The Extraordinary General Meeting Of The Company Held On June 29, 2022 In Accordance With Regulation 44(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
The Extraordinary General Meeting of the Company was held on Wednesday, 29th June, 2022 at 12:30 p.m. through Video Conferencing / Other Audio-Visual Means. Pursuant to the requirements of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith particulars of voting results of voting conducted through Remote E-voting and voting through electronic system during the EGM in respect of all the resolutions as set out in the Notice dated 07th June, 2022. We also enclose herewith the Scrutinizer's Consolidated Report. All the resolutions set out in the Notice of the EGM were approved with the requisite majority. Zim Laboratories Ltd - 541400 - Closure of Trading Window
This is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, BSE Circular No. LIST/COMP/2019-20 dt. 02nd April, 2019, and Company's Code of Conduct to Regulate, Monitor and Report Trading by Insider's, the trading window for dealing with securities of the Company will remain closed from Friday the 01st July, 2022, for 'Designated Persons', including Promoters / Directors / Key Managerial Personnel / Designated employees of the company and their immediate relatives. Zim Laboratories Ltd - 541400 - Disclosure Under Regulation 30 - Proceedings Of Extraordinary General Meeting.
The Extraordinary General Meeting of the Company was held on 29th June, 2022 at 12:30 p.m. through VC/OAVM and in this regard, please find enclosed proceedings of the Extraordinary General Meeting as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith a copy of newspaper advertisements published on 08.06.2022, in respect of Extraordinary General Meeting of the Company scheduled to be held on 29.06.2022, in the following Newspaper :- 1) The Financial Express (English) all India Edition 2) Indian Express (English) Nagpur Edition 3) Loksatta (Marathi) Newspaper. Zim Laboratories Ltd - 541400 - Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Notice Of The Extraordinary General Meeting (EGM) Of Shareholders Of The Company.
In continuation to our letter dated 07.06.2022, wherein we had intimated that the Notice for convening the Extraordinary General Meeting (EGM) of the Company has been sent to Shareholders, we would like to inform you that there is a typographical error in Resolution No. 6 of the Notice and its explanatory statement thereto which has been rectified. The revised notice has been sent to the shareholders through electronic mode and the same is enclosed herewith for your reference. The revised notice of EGM is also available on Company's website at www.zimlab.in. Zim Laboratories Ltd - 541400 - Notice Of The Extraordinary General Meeting (EGM) Of Shareholders Of The Company.
In continuation to our letter dated 06.06.2022, wherein we had intimated that the Board of Directors have approved issuance of Notice for convening the Extraordinary General Meeting of the Company, please find enclosed the EGM Notice dated 06.06.2022 under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015 seeking the consent of the shareholders on the matters set out in the notice, which is being sent though electronic mode to members of the Company. The notice of EGM is also available on Company's website at www.zimlab.in.